Establishment of a functional ovine fetoplacental artery endothelial cell line with a prolonged life span

Biology of Reproduction

Volumn 76, Issue 1, 2007, Pages 29-35

  Song, Yang ^a   Zheng, Jing ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Cell proliferation; Growth factors; Kinases; Mitogen activated protein kinase 3 1; Nitric oxide; Placenta; Placental endothelial cells; Signal transduction; Simian virus 40; v akt murine thymoma viral oncogen homolog 1

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ACETYL LOW DENSITY LIPOPROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBROBLAST GROWTH FACTOR 2; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; VASCULOTROPIN; VIRUS LARGE T ANTIGEN; VIRUS SMALL T ANTIGEN;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CAPILLARY; CELL AGING; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FETOPLACENTAL UNIT; GENE; GENETIC TRANSFECTION; IMMUNOCYTOCHEMISTRY; LIFESPAN; NEOMYCIN RESISTANCE GENE; NONHUMAN; PHENOTYPE; PLASMID; PRIORITY JOURNAL; SHEEP; SIMIAN VIRUS 40;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ARTERIES; CELL LINE, TRANSFORMED; CELL PROLIFERATION; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PLACENTA; PLASMIDS; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; SHEEP, DOMESTIC; SIMIAN VIRUS 40; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MURINAE; OVIS; SIMIAN VIRUS 40;

EID: 33845746208     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.106.055921     Document Type: Article

References (32)

1. Reynolds LP, Redmer DA. Utero-placental vascular development and placental function. J Anim Sci 1995; 73:1839-1851.
2. Magness RR, Zheng J. Maternal cardiovascular alterations during pregnancy. In: Gluckman PD, Heymann MA, (eds.). Pediatric and Perinatal Perspectives: The Scientific Basic. London: Edward Arnold Publishers; 1996:762-772.
3. Mayhew TM, Charnock-Jones DS, Kaufmann P. Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta 2004; 25:127-139.
4. Zheng J, Bird IM, Chen DB, Magness RR. Angiotensin II regulation of ovine fetoplacental artery endothelial functions: interactions with nitric oxide. J Physiol 2005; 565:59-69.
5. Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. Am J Physiol 1997; 272:R441-463.
6. Zheng J, Bird IM, Melsaether AN, Magness RR. Activation of the mitogen-activated protein kinase cascade is necessary but not sufficient for basic fibroblast growth factor- and epidermal growth factor-stimulated expression of endothelial nitric oxide synthase in ovine fetoplacental artery endothelial cells. Endocrinology 1999; 140:1399-1407.
7. Neufeld DS, Ripley S, Henderson A, Ozer HL. Immortalization of human fibroblasts transformed by origin-defective simian virus 40. Mol Cell Biol 1987; 7:2794-2802.
8. Gazdar AF, Butel JS, Carbone M. SV40 and human tumours: myth, association or causality? Nat Rev Cancer 2002; 2:957-964.
9. Comerford SA, Clouthier DE, Hinnant EA, Hammer RE. Induction of hepatocyte proliferation and death by modulation of T-antigen expression. Oncogene 2003; 22:2515-2530.
10. Ahuja D, Saenz-Robles MT, Pipas JM. SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 2005; 24:7729-7745.
11. Arroyo JD, Hahn WC. Involvement of PP2A in viral and cellular transformation. Oncogene 2005; 24:7746-7755.
12. Muruganandam A, Herx LM, Monette R, Durkin JP, Stanimirovic DB. Development of immortalized human cerebromicrovascular endothelial cell line as an in vitro model of the human blood-brain barrier. FASEB J 1997; 11:1187-1197.
13. Hohenwarter O, Waltenberger A, Strutzenberger K, Katinger H. Human endothelial cell lines established by mutated forms of the simian virus 40 large T oncogene. J Biotechnol 1997; 54:131-137.
14. Fitzgerald U, Hettle S, Macdonald C, Mclean JS. Umbilical cord endothelial cells expressing large T antigen: comparison with primary cultures and effect of cell age. In Vitro Cell Dev Biol Anim 2000; 36:222-227.
15. Schutz M, Teifel M, Friedl P. Establishment of a human placental endothelial cell line with extended life span after transfection with SV40 T-antigens. Eur J Cell Biol 1997; 74:315-320.
16. Cross MJ, Claesson-Welsh L. FGF and VEGF function in angiogenesis: signaling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 2001; 22:201-207.
17. Cuevas P, Carceller F, Ortega S, Zazo M, Nieto I, Gimenez-Gallego G. Hypotensive activity of fibroblast growth factor. Science 1991; 254:1208-1210.
18. Ku DD, Zaleski JK, Liu S, Brock TA. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 1993; 265:H586-H592.
19. Kadota O, Ohta S, Kumon Y, Sakaki S, Matsuda S, Sakanaka M. Role of basic fibroblast growth factor in the regulation of rat basilar artery tone in vivo. Neurosci Lett 1995; 199:99-102.
20. Ni Y, May V, Braas K, Osol G. Pregnancy augments utero placental vascular endothelial growth factor (VEGF) gene expression and vasodilators in rat uterine circulation. Am J Physiol 1997; 273:H938-944.
21. Kostyk SK, Kourembanas S, Wheeler EL, Medeiros D, McQuillan LP, D'Amore PA, Braunhut SJ. Basic fibroblast growth factor increases nitric synthase production in bovine endothelial cells. Am J Physiol 1995; 269:H1583-1589.
22. Li Y, Zheng J, Bird IM, Magness RR. Effects of pulsatile shear stress on nitric oxide production and endothelial cell nitric oxide synthase expression by ovine fetoplacental artery endothelial cells. Biol Reprod 2003; 69:1053-1059.
23. Litzkas P, Jha KK, Ozer HL. Efficient transfer of cloned DNA into human diploid cells: protoplast fusion in suspension. Mol Cell Biol 1984; 4:2549-2552.
24. Zheng J, Wen Y, Chen DB, Bird IM, Magness RR. Angiotensin II elevates nitric oxide synthase 3 expression and nitric oxide production via a mitogen-activated protein kinase cascade in ovine fetoplacental artery endothelial cells. Biol Reprod 2005; 72:1421-1428.
25. Zhao JJ, Gjoerup OV, Subramanian RR, Cheng Y, Chen W, Roberts TM, Hahn WC. Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell 2003; 3:483-495.
26. Harada T, Batsford S, Morioka T, Yao J, Arakawa M, Gejyo F, Oite T. Establishment of immortalized human glomerular endothelial cell lines and their application. Nephron Exp Nephrol 2005; 99:e38-45.
27. Kirchhofer D, Languino LR, Ruoslahti E, Pierschbacher MD. Alpha 2 beta 1 integrins from different cell types show different binding specificities. J Biol Chem 1990; 265:615-618.
28. Pace MC, Chambliss KL, German Z, Yuhanna IS, Mendelsohn ME, Shaul PW. Establishment of an immortalized fetal intrapulmonary artery endothelial cell line. Am J Physiol Lung Cell Mol Physiol 1999; 277:L106-112.
29. Greif DM, Kou R, Michel T. Site-specific dephosphorylation of endothelial nitric oxide synthase by protein phosphatase 2A: evidence for crosstalk between phosphorylation sites. Biochemistry 2002; 41:15845-15853.
30. Michell BJ, Chen ZP, Tiganis T, Stapleton D, Katsis F, Power DA, Sim AT, Kemp BE. Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem 2001; 276:17625-17628.
31. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999; 399:597-601.
32. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999; 399:601-605.